Malignant Tumor of Ill-defined Site

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-02-02
Clinical Trial Update: LCI-NOS-PAIN-001: A Prospective, Pharmacogenomic-Driven Study of Pain Management in Oncology Outpatients [Phase 2]
Phase 2 pharmacogenomic-driven study on pain management in oncology outpatients was terminated; results posted in 2021.